Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Torti

Showing results (171-180 of 263) with videos related to

Pageof 27
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|February 28, 2015
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected PatientsGiuseppe Lapadula, Silvia Costarelli, Liliane Chatenoud, et al.
Viruses|February 28, 2023
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome EvolutionClaudia Veneziano, Nadia Marascio, Carmela De Marco, et al.
Biomedicines|July 27, 2022
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of MethylprednisoloneAlessandro Russo, Chiara Davoli, Cristian Borrazzo, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 14, 2025
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based studySalvatore Rotundo, Salvatore Nisticò, Helen Linda Morrone, et al.
Artificial Intelligence in Medicine|June 16, 2009
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapyDechao Wang, Brendan Larder, Andrew Revell, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2007
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral loadCarlo Torti, Giuseppe Lapadula, Pablo Barreiro, et al.
Mediators of Inflammation|March 15, 2018
Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria RegionGiovanni Matera, Maria Teresa Loria, Cinzia Peronace, et al.
Antiviral Therapy|May 17, 2007
The development of artificial neural networks to predict virological response to combination HIV therapyBrendan Larder, Dechao Wang, Andrew Revell, et al.
Clinical and Molecular Hepatology|April 25, 2018
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antiviralsAlessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 14, 2011
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenzLaura Albini, Bruno Mario Cesana, Davide Motta, et al.
Pageof 27

Showing results (171-180 of 263) with videos related to

Sort By:
Pageof 27
Journal of Acquired Immune Deficiency Syndromes (1999)|February 28, 2015
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected PatientsGiuseppe Lapadula, Silvia Costarelli, Liliane Chatenoud, et al.
Viruses|February 28, 2023
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome EvolutionClaudia Veneziano, Nadia Marascio, Carmela De Marco, et al.
Biomedicines|July 27, 2022
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of MethylprednisoloneAlessandro Russo, Chiara Davoli, Cristian Borrazzo, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 14, 2025
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based studySalvatore Rotundo, Salvatore Nisticò, Helen Linda Morrone, et al.
Artificial Intelligence in Medicine|June 16, 2009
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapyDechao Wang, Brendan Larder, Andrew Revell, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2007
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral loadCarlo Torti, Giuseppe Lapadula, Pablo Barreiro, et al.
Mediators of Inflammation|March 15, 2018
Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria RegionGiovanni Matera, Maria Teresa Loria, Cinzia Peronace, et al.
Antiviral Therapy|May 17, 2007
The development of artificial neural networks to predict virological response to combination HIV therapyBrendan Larder, Dechao Wang, Andrew Revell, et al.
Clinical and Molecular Hepatology|April 25, 2018
Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antiviralsAlessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 14, 2011
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenzLaura Albini, Bruno Mario Cesana, Davide Motta, et al.
Pageof 27